[Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection].
This article presents the results of monitoring in a group of children with severe forms of acute respiratory viral infection and toxic encephalopathy. Hemorheological disorder in the form of hyperviscosity syndrome has been detected in all patients with severe forms of acute respiratory viral infection. It was suggested the inclusion of cytoflavin in the complex therapy for correcting the hemorheological status. The administration of cytoflavin led to reduction of erythrocyte aggregation and general improvements in rheological indices of children with severe forms of acute respiratory viral infection and toxic encephalopathy.
E V
EV
Mikhaĭlova
A N
AN
Danilova
T K
TK
Chudakova
A V
AV
Romanovskaia
N A
NA
Dubovitskaia
A E
AE
Belova
D000208:Acute Disease; D001809:Blood Viscosity / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D005260:Female; D005486:Flavin Mononucleotide / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D007290:Inosine Diphosphate / Q000008:administration & dosage*; D008297:Male; D020258:Neurotoxicity Syndromes / Q000097:blood / Q000188:drug therapy; D009536:Niacinamide / Q000008:administration & dosage*; D012141:Respiratory Tract Infections / Q000097:blood / Q000188:drug therapy; D013386:Succinates / Q000008:administration & dosage*; D014777:Virus Diseases / Q000097:blood / Q000188:drug therapy
D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate